<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE paragraph PUBLIC "-//IFRS//DTD DITA Paragraph//EN" "../../../DocTypes/com.ifrs.doctype/dtd/paragraph.dtd"><paragraph id="IAS41_54" base="SL33647" principles="yes"><paranum class="- topic/title paragraph/paranum "/><titlealts><navtitle>54</navtitle></titlealts><prolog><data name="standard_number" value="IAS 41"/><data name="paranum" value="54"/></prolog><body outputclass="bold"><p id="IAS41_P0227">If an entity measures biological assets at their cost less any accumulated depreciation and any accumulated impairment losses (see <xref id="IAS41_X0164" base="F1100568" href="IAS41_g30-33.dita#IAS41_g30-33/IAS41_g30-33_TI">paragraph 30</xref>) at the end of the period, the entity shall disclose for such biological assets: </p><ol outputclass="static" id="IAS41_L0017" base="SL143306" type="lower-alpha"><li id="IAS41_54_a"><li_value>(a)</li_value>         <p id="IAS41_P0228" base="SL143308">a description of the biological assets;</p>       </li><li id="IAS41_54_b"><li_value>(b)</li_value>         <p id="IAS41_P0229" base="SL143310">an explanation of why fair value cannot be measured reliably;</p>       </li><li id="IAS41_54_c"><li_value>(c)</li_value>         <p id="IAS41_P0230" base="SL143312">if possible, the range of estimates within which fair value is highly likely to lie;</p>       </li><li id="IAS41_54_d"><li_value>(d)</li_value>         <p id="IAS41_P0231" base="SL143314">the depreciation method used;</p>       </li><li id="IAS41_54_e"><li_value>(e)</li_value>         <p id="IAS41_P0232" base="SL143316">the useful lives or the depreciation rates used; and</p>       </li><li id="IAS41_54_f"><li_value>(f)</li_value>         <p id="IAS41_P0233" base="SL143318">the gross carrying amount and the accumulated depreciation (aggregated with accumulated impairment losses) at the beginning and end of the period.</p>       </li></ol></body></paragraph>